What is target weight in dialysis

Extra fluid can be dangerous and cause extra strain on your body, especially  your heart and lungs. Fluid overload can lead to recurrent  admissions to hospital with elevated blood pressure , congestive heart failure and have heart attacks.

Your dry weight is measured in kilograms. One kilogram is 2.2 pounds.  Most hemodialysis patients are advised to limit their weight gain per treatment to no more than 1 kilogram per day (2.2 pounds) between dialysis sessions. 1 kilogram may not sound like a lot.  However, when you think of it as almost 4-7 pounds of fluid that needs to be removed, you can start to see how important it is to limit how much fluid you take in  between treatments.

The amount of fluid that could be removed in a dialysis session is restricted. As too much fluid removal in one session can cause problems with low blood pressure, dizziness or loss of consciousness ,  leg cramps and heart problems. 

Things you can do to help :

Our team at kingwood kidney associates can help attain dry weight based on your needs. In general,

  • Watch your fluid intake. 
  • Most hemodialysis patients should not drink more  than 32 ounces per day.  
  • Follow a kidney-friendly diet. 
  • Avoid salty foods. Salt makes your body hold on to extra fluid.  It will also make you thirstier, which makes it harder to control your fluid intake between treatments.
  • Keep track of your daily weight. Keeping track of your weight is important between dialysis sessions. 

You know you are at dry weight if 

  • Your blood pressure is within your normal range after dialysis or before your next session.
  • You do not experience lightheadedness or cramping during or between dialysis sessions .
  • You do not have swelling in your legs, feet, arms, hands, or around your eyes.
  • Your breathing is comfortable and easy.

Call  us at kingwood kidney associates 281-401-9540 to schedule your appointment to learn about dialysis and learn more about dry weight . 

You can also schedule your appointment online using the booking tool on this page. Book your examination today.

Author

Dr. Sowmya Puthalapattu Sowmya Puthalapattu, MD, or Dr. Sowmya as she’s known to patients, is an experienced board-certified nephrologist and internal medicine physician at Kingwood Kidney Associates, with offices in Kingwood and The Woodlands, Texas. Dedicated to providing her patients with comprehensive individualized care, Dr. Puthalapattu believes in the importance of active listening and having an open and creative clinical mind to provide the right care to meet her patients’ needs. She is faculty and Subspeciality education coordinator for Nephrology at IM GME program HCA Kingwood . Her areas of specialty include chronic kidney disease, end-stage renal disease, hyponatremia, and high blood pressure. A resident of The Woodlands, Texas, Dr. Puthalapattu spends her free time with her husband and two children. Her favorite activities include hiking and traveling.

Medications and low sodium ( Hyponatremia ) in older adults

Low blood sodium (hyponatremia) occurs when you have an abnormally low amount of sodium in your blood or when you have too much water in your blood. Low blood sodium is common in older adults, especially those who are hospitalized or living in long-term ca

PREVENTION AND TREATMENT OF HYPONATREMIA ( LOW SODIUM )

In hyponatremia, one or more factors causes the sodium in your body to become diluted. When this happens, your body's water levels rise, and your cells begin to swell. This swelling can cause many health problems, from mild to life-threatening.

LOW SODIUM ( HYPONATREMIA )

Hyponatremia occurs when the concentration of sodium in your blood is abnormally low. Low sodium can result in potentially dangerous effects, such as rapid brain swelling leading to coma and death. Older adults are at higher risk for low sodium levels .

TREATMENT OF HIGH POTASSIUM

There are medications which can help lower your potassium levels when following a low potassium diet is not enough .

Background: Hemodialysis (HD) patients are exposed to a high risk of death. Nutritional status has been recognized as a key factor for patient survival. Nutritional markers have been shown to improve after HD onset. In this study we have analyzed the dynamics of target weight (TGW) change and the evolution of other nutritional parameters during the first year of HD treatment and their influence on patients' outcomes. Methods: We have analyzed a retrospective cohort of incident patients starting HD therapy between January 2000 and January 2009, and studied the values and changes in TGW, interdialytic weight gain (IDWG), predialysis systolic blood pressure, serum albumin, protein intake, C-reactive protein (CRP) from the start and first week (W1), W8, W12, W26 and W52 in patients who survived the first year of therapy. We have analyzed the relationship between TGW changes with other nutritional parameters and the patient survival. Results: Among the cohort including 363 patients starting HD therapy, 251 (age 65.8 ± 14.8 years, 93 female/158 male, diabetes 36%) survived at least 1 year after dialysis onset and were followed for 44.9 months. During the first 8 weeks, the TGW decreased by 6.5 ± 5.6% (initial TGW change). The initial TGW change was correlated with IDWG at W12 and W26, and with changes in serum albumin and nPNA (normalized protein equivalent of nitrogen appearance) between HD W1 and W52 (respectively +7.8 and +11.4%). From W8 to W52, the TGW increased by +1.9 ± 7.4% (secondary TGW change). The Kaplan-Meier analysis displayed a significantly better survival in patients above the median (+2.3%) of the secondary TGW change (respectively -3.6 ± 5.2% and +7.6 ± 4.5%). The two groups above and below this median were not different according to age, diabetes or cardiovascular event history but the patients above the median had a significant higher IDWG and protein intake. In the Cox model analysis the patient overall mortality was related to age (p < 0.0001), to the secondary TGW change (p = 0.0001), and to the CRP level at W52 (p < 0.0001). Conclusions: The initial fluid removal was related to nutritional markers. The secondary TGW change during the first year of HD treatment calculated after the initial phase of fluid removal was identified as a strong predictor of survival. It was associated with a better food intake whereas the patient case mix was not different. These data highlight the importance of nutrition and food intake in the first year of dialysis therapy and the need for nutritional follow-up and support in incident HD patients. It stresses the need in understanding the key factors associated with food intake in this setting.

© 2014 S. Karger AG, Basel

References

  1. Goodkin DA, Young EW, Kurokawa K, Prutz KG, Levin NW: Mortality among hemodialysis patients in Europe, Japan, and the United States: case-mix effects. Am J Kidney Dis 2004;44:16-21.
  2. Pifer TB, McCullough KP, Port FK, et al: Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 2002;62:2238-2245.
  3. Gama-Axelsson T, Heimburger O, Stenvinkel P, Barany P, Lindholm B, Qureshi AR: Serum albumin as predictor of nutritional status in patients with ESRD. Clin J Am Soc Nephrol 2012;7:1446-1453.
  4. De Mutsert R, Grootendorst DC, Indemans F, Boeschoten EW, Krediet RT, Dekker FW: Association between serum albumin and mortality in dialysis patients is partly explained by inflammation, and not by malnutrition. J Ren Nutr 2009;19:127-135.
  5. Pupim LB, Caglar K, Hakim RM, Shyr Y, Ikizler TA: Uremic malnutrition is a predictor of death independent of inflammatory status. Kidney Int 2004;66:2054-2060.
  6. Mehrotra R, Berman N, Alistwani A, Kopple JD: Improvement of nutritional status after initiation of maintenance hemodialysis. Am J Kidney Dis 2002;40:133-142.
  7. Dalrymple LS, Johansen KL, Chertow GM, et al: Longitudinal measures of serum albumin and prealbumin concentrations in incident dialysis patients: the comprehensive dialysis study. J Renal Nutr 2013;23:91-97.
  8. Chazot C, Charra B, Vo Van C, et al: The Janus-faced aspect of ‘dry weight'. Nephrol Dial Transplant 1999;14:121-124.
  9. Chazot C, Vo-Van C, Deleaval P, et al: Predialysis systolic blood pressure evolution in incident hemodialysis patients: effects of the dry weight method and prognostic value. Blood Purif 2012;33:275-288.
  10. Charra B, Laurent G, Chazot C, et al: Clinical assessment of dry weight. Nephrol Dial Transplant 1996;11:16-19.
  11. Jean G, Charra B, Chazot C, Laurent G: Quest for postdialysis urea rebound-equilibrated Kt/V with only intradialytic urea samples. Kidney Int 1999;56:1149-1153.
  12. Kalantar-Zadeh K, Abbott KC, Salahudeen AK, Kilpatrick RD, Horwich TB: Survival advantages of obesity in dialysis patients. Am J Clin Nutr 2005;81:543-554.
  13. Chazot C, Gassia JP, Di Benedetto A, Cesare S, Ponce P, Marcelli D: Is there any survival advantage of obesity in Southern European haemodialysis patients? Nephrol Dial Transplant 2009;24:2871-2876.
  14. Pupim LB, Kent P, Caglar K, Shyr Y, Hakim RM, Ikizler TA: Improvement in nutritional parameters after initiation of chronic hemodialysis. Am J Kidney Dis 2002;40:143-151.
  15. Chazot C, Jean G, Vo-Van C, et al: The plasma level of brain natriuretic peptide is increased in malnourished hemodialysis patients. Blood Purif 2009;28:187-192.
  16. Lopes AA, Elder SJ, Ginsberg N, et al: Lack of appetite in haemodialysis patients - associations with patient characteristics, indicators of nutritional status and outcomes in the international DOPPS. Nephrol Dial Transplant 2007;22:3538-3546.

First-Page Preview

Received: September 11, 2013Accepted: March 06, 2014Published online: April 15, 2014

Issue release date: June 2014

Number of Print Pages: 7 Number of Figures: 5

Number of Tables: 5


eISSN: 1660-2110 (Online)

For additional information: //www.karger.com/NEC

Postingan terbaru

LIHAT SEMUA